Pharmacology

Royal Canin is highlighting the importance of a personalized health plan based on each pets' unique needs with these products and designated day for awareness

Lee Pope, DVM, discusses dosage tips to share with pet owners in a dvm360 interview.

Dechra’s Otiserene is a single-dose, long-acting product that utilizes marbofloxacin

Visible particulate matter was observed in 2 products containing dexmedetomidine hydrochloride injection 0.5 mg/mL for dogs and cats.

The nutraceutical 4CYTE Epiitalis Forte Dog was previously only available abroad and is now distributed domestically by epiq Animal Health and Interpath Global.

OST-HER2 could be a frontline treatment for dogs and humans

The STAY study is investigating LOY-002, a therapy designed by Loyal to extend healthy lifespans in canines

The FDA has approved the new indication for Zoetis' Simparica Trio

Treating separation anxiety requires behavioral modification and medication, but which drug should you choose?

The entire hive can be treated for common bacterial diseases

Current levels of pain management administration by dairy producers and veterinarians in Europe and North America are low.

Felixvet has introduced a carprofen therapy with the same therapeutic benefits as Rimadyl

Communications expert Wendy S. Myers provides scripts for confident client conversations

In a dvm360 interview, Lee Pope, DVM, shares what veterinarians most-often request of their patients' medications.

Zoetis has launched its’ 0.5 mL dose for intranasal Vanguard B

Longevity drug developer Loyal and pain therapy manufacturer Elanco Animal Health are working with the organization to promote the need for aging canine care and enhance veterinary resources.

Jb Minter, DVM, MS, DACZM, discusses potential complications that can arise when amphibians are under anesthesia

William Murphy, PhD, BS, was selected by SEC provosts for the recognition, from among 16 previous achievement award recipients

In this interview, Jb Minter, DVM, MS, DACZM, talks about amphibian metabolism, drug processing, and more

Felycin-CA1 manages ventricular hypertrophy in feline patients with subclinical hypertrophic cardiomyopathy

DuOtic received FDA approval March 2024 to treat canine patients

Casey Locklear, DVM, discussed the combination drug’s efficacy and administration of the therapy, during an interview with dvm360.

These natural and pharmaceutical therapies aid by reducing the reabsorption of sodium and water

Rachel Venable, DVM, MS, DACVIM (Oncology) discussed what primary doctors can do to treat their patients with cancer when clients decline specialty care during a WVC 2025 CE session